Otonomy

Otonomy brings out the ax after a catastrophic PhIII failure
Otonomy brings out the ax after a catastrophic PhIII failure
Endpoints
Otonomy
Meniere's Disease
layoffs
clinical trials
Flag link:
Otonomy staggered by an ugly PhIII failure for lead pipeline drug
Otonomy staggered by an ugly PhIII failure for lead pipeline drug
Endpoints
Otonomy
clinical trials
Otividex
Meniere's Disease
Flag link:
Otonomy wins FDA approval for a first-of-its-kind ear treatment
Otonomy wins FDA approval for a first-of-its-kind ear treatment
Fierce Biotech
Otonomy
FDA
ear infections
Otiprio
Flag link:
Otonomy heads to the clinic with a tinnitus drug
Otonomy heads to the clinic with a tinnitus drug
Fierce Biotech
Otonomy
tinnitus
FDA
OTO-311
Flag link:
Otonomy Inc's ear drug fails mid-stage trial
Otonomy Inc's ear drug fails mid-stage trial
Yahoo/Reuters
Otonomy
Meniere's Disease
Flag link:
2014's most successful biotech IPOs
2014's most successful biotech IPOs
Fierce Biotech
IPOs
biotech
Ultragenyx
ZS Pharma
Auspex Pharmaceuticals
Avalanche Biotechnologies
SAGE Therapeutics
Kite Pharma
Otonomy
Zafgen
ProQR
Radius Health
Flag link:
Otonomy heads to the FDA after its ear treatment clears Phase III
Otonomy heads to the FDA after its ear treatment clears Phase III
Fierce Biotech
Otonomy
FDA
AuriPro
OTO-201
ear tubes
Flag link:
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
JPMHC 2014
Algeta
Macrogenics
Xencor
Acetylon
Enanta Pharmaceuticals
Clinigen
Iroko Pharmaceuticals
Protalix BioTherapeutics
Ambrx
Roche
Sialix
Verastem
pRED
Cubist Pharmaceuticals
Celgene
Otonomy
Lumena Pharmaceuticals
Flag link: